Biotalys NV

Biotalys Starts Field Trials for Second Biofungicide

02 May 2024 01:00:00 By Nasdaq GlobeNewswire

Biotalys Appoints Laura J. Meyer to Board of Directors

30 Apr 2024 01:00:00 By Nasdaq GlobeNewswire

Results of the Ordinary and Extraordinary Shareholders’ Meeting

23 Apr 2024 12:00:00 By Nasdaq GlobeNewswire

Results of the Special Shareholders’ Meeting

29 Mar 2024 13:00:00 By Nasdaq GlobeNewswire

Invitation to the ordinary general shareholders meeting and an extraordinary shareholders meeting

20 Mar 2024 13:00:00 By Nasdaq GlobeNewswire

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

18 Mar 2024 02:00:00 By Nasdaq GlobeNewswire

Invitation to a Special Shareholders’ Meeting

26 Feb 2024 12:00:00 By Nasdaq GlobeNewswire

Biotalys Reports Full-Year 2023 Financial Results and Business Highlights

22 Feb 2024 01:00:00 By Nasdaq GlobeNewswire

Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.

08 Feb 2024 01:00:00 By Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

31 Jan 2024 12:00:00 By Nasdaq GlobeNewswire

Biotalys Notice of Full Year 2023 Results and Business Highlights

22 Jan 2024 12:00:00 By Nasdaq GlobeNewswire

Biotalys Announces Results of Independent Field Trials in the U.S.

19 Dec 2023 01:00:00 By Nasdaq GlobeNewswire

Biotalys Provides Company Update

29 Nov 2023 01:00:00 By Nasdaq GlobeNewswire

Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

02 Oct 2023 01:00:00 By Nasdaq GlobeNewswire

Biotalys announces participation at upcoming scientific, industry and investor events

26 Sep 2023 01:00:00 By Nasdaq GlobeNewswire

Biotalys Reports Half-Year 2023 Financial Results and Business Highlights

23 Aug 2023 01:00:00 By Nasdaq GlobeNewswire

Invitation to a Special Shareholders’ Meeting

20 Jul 2023 01:00:00 By Nasdaq GlobeNewswire

Publication of transparency notification

05 Jul 2023 12:00:00 By Nasdaq GlobeNewswire

Biotalys announces closing of private placement

12 Jun 2023 12:00:00 By Nasdaq GlobeNewswire

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

07 Jun 2023 01:00:00 By Nasdaq GlobeNewswire